CAS: 1159-15-5; Tos-Arg-Oh

相似化合物

1119-34-2 114622-81-0 1234-35-1

上下游产品

CAS号74-79-3 L-精氨酸 | CAS号98-59-9 对甲苯磺酰氯(PTSC) | CAS号2440-60-0 O-甲基异脲 | CAS号3304-51-6 N'-Cbz-L-鸟氨酸 | CAS号110414-90-9 N5-benzyloxycar... | CAS号102081-75-4 N-(toluene-4-su... | CAS号42533-20-0 N-(toluene-4-su... | CAS号124288-95-5 4-methyl-N-(2-o... | CAS号14279-64-2 N-对甲苯磺酰基-L-精氨酰胺盐酸盐 | CAS号74-79-3 L-精氨酸 | CAS号1784-03-8 Nα-对甲苯磺酰基-L-精氨酸甲酯盐酸盐

📜N5-Benzyloxycarbonyl-N2-(Toluene-4-Sulfonyl)-Dl-Ornithine置于甲醇,氨,钯,溶剂黄146体系中,化学反应生成N-对甲苯磺酰基-L-精氨酸
参考文献:611.碱性氨基酸肽衍生物的合成
标题:611.碱性氨基酸肽衍生物的合成
摘要:
Doi:10.1039/jr9570003134

专利信息

专利号:US-7354923-B2
优先权日:2001-08-10
标 题 :Piperazine melanocortin-specific compounds
发明人：SHARMA SHUBH D; SHI YI-QUN; WU ZHIJUN; RAJPUROHIT RAMESH
权利人:PALATIN TECHNOLOGIES INC
摘要:Melanocortin receptor-specific piperazine or ketopiperazine compounds having the structure: n nand stereoisomer and pharmaceutically acceptable salts thereof, where X is CH 2 or Câ•?O, R 1 , R 2 , and R 3 are as described in the specification, preferably where R 3 is a D-amino acid with at least one substituted or unsubstituted phenyl or naphthyl aromatic ring, and where R 3 optionally further includes an amine capping group, a second amino acid residue or a second amino acid residue with an amine capping group, which compounds are agonists, antagonists or mixed agonists and antagonists at one or more melanocortin receptors, and having utility in the treatment of melanocortin receptor-related disorders and conditions. Methods of synthesis of compounds of structure (I), pharmaceutical compositions containing a compound of structure (I) and methods relating to the use thereof are also disclosed.

专利号:WO-2005102340-A1
优先权日:2003-05-30
标题 :Piperazine melanocortin-specific compounds
发明人：SHARMA SHUBH D; SHI YI-QUN; WU ZHIJUN; RAJPUROHIT RAMESH
权利人:PALATIN TECHNOLOGIES INC; SHARMA SHUBH D; SHI YI-QUN; WU ZHIJUN; RAJPUROHIT RAMESH
摘要:Melanocortin receptor-specific piperazine or ketopiperazine compounds having the structure (I); and stereoisomer and pharmaceutically acceptable salts thereof, where X is CH2 or C=O, R1, R2, and R3 are as described in the specification, preferably where R3 is a D-amino acid with at least one substituted or unsubstituted phenyl or naphthyl aromatic ring, and where R3 optionally further includes an amine capping group, a second amino acid residue or a second amino acid residue with an amine capping group, which compounds are agonists, antagonists or mixed agonists and antagonists at one or more melanocortin receptors, and having utility in the treatment of melanocortin receptor-related disorders and conditions. Methods of synthesis of compounds of structure (I), pharmaceutical compositions containing a compound of structure (I) and methods relating to the use thereof are also disclosed.